- ►shouxi.net AM Shapiro, C Ricordi, BJ Hering, H … - New England Journal of Medicine, 2006 - content.nejm.org AM James Shapiro, MD, Ph.D., Camillo Ricordi, MD, Bernhard J. Hering, MD, Hugh
Auchincloss, MD, Robert Lindblad, MD, R. Paul Robertson, MD, Antonio Secchi, MD,
Mathias D. Brendel, MD, Thierry Berney, MD, Daniel C. Brennan, MD, Enrico ... Cited by 395 - Related articles - BL Direct - All 9 versions
DM Rothstein, MH Sayegh - Immunological reviews, 2003 - interscience.wiley.com Summary: The destiny of activated T cells is critical to the ultimate fate of
immune response. After encountering antigen, naïve T cells receive signal 1
through the T-cell receptor (TCR)-major histocompatibility complex (MHC) ... Cited by 135 - Related articles - BL Direct - All 7 versions
- ►jimmunol.org AB Adams, N Shirasugi, TR Jones, MM Durham … - The Journal of Immunology, 2005 - Am Assoc Immnol In recent years, reagents have been developed that specifically target signals
critical for effective T cell activation and function. Manipulation of the
CD28/CD80/86 and CD40/CD154 pathways has exhibited extraordinary efficacy, ... Cited by 79 - Related articles - All 8 versions
J Shapiro… - Transplantation, 2005 - journals.lww.com We gratefully acknowledge ongoing support from a Clinical Center for Islet
Transplantation Grant from the Juvenile Diabetes Research Foundation, Capital
Health and the Province Wide Services of the Government of Alberta, the ... Cited by 68 - Related articles - BL Direct - All 4 versions
O Korsgren, B Nilsson, C Berne, M Felldin, A … - Transplantation, 2005 - journals.lww.com Transplantation. Wolters Kluwer Health Logo. All Issues. ... Cited by 64 - Related articles - BL Direct - All 5 versions
JB Matthews, E Ramos, JA Bluestone - American Journal of Transplantation, 2003 - interscience.wiley.com The search for tolerance therapies that would thwart the alloimmune response
following organ transplantation while preserving a patient's protective immune
response has been a formidable goal for clinical immunologists. Over the ... Cited by 57 - Related articles - BL Direct - All 6 versions
- ►asnjournals.org F Vincenti - Journal of the American Society of Nephrology, 2003 - Am Soc Nephrol The past decade has witnessed unprecedented advances in renal transplantation
propelled by novel and effective immunosuppression drugs. The introduction of
mycophenolate mofetil (MMF), tacrolimus, cyclosporine microemulsion, ... Cited by 54 - Related articles - BL Direct - All 5 versions
MR Clarkson, MH Sayegh - Transplantation, 2005 - journals.lww.com A key factor driving the underlying pathyphysiology of chronic rejection in
organ transplantation is a persistent T cell-mediated alloimmune response.
Members of both the B7 family (including CD28 and CTLA4) and the tumor ... Cited by 47 - Related articles - BL Direct - All 3 versions
AD Kirk - Immunological reviews, 2003 - prsjournal.com Many methods for reducing the immunosuppressive requirements of
allotransplantation have been proposed based on a growing understanding of
physiological and allospecific immunity. As these regimens are developed ... Cited by 49 - Related articles - Cached - BL Direct - All 6 versions
